MENU
SNGX
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Soligenix (SNGX) Ownership - Who owns Soligenix?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.57M
P/E Ratio
N/A
Total Cash
9.41M
Projected Growth
N/A
Total Debt
2.92M
Revenue
N/A
Risk (Beta)
2.36
Dividend Yield
N/A
Total Cash/Share
4.13
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SNGX
Capitalization
8.57M
P/E Ratio
N/A
Risk (Beta)
2.36
Dividend Yield
N/A
Total Cash
9.41M
Total Cash/Share
4.13
Total Debt
2.92M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.47M
P/B Ratio
2.60
Cash Flow
N/A
Earnings
-8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.54K
Current Ratio
1.52
Current Revenue Per Employee
7801.93
Dividends Per Share - Security
N/A
EBITDA
-7.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
0.00
Revenue To Assets
-59.45
Shares Held By Institutions
345K
Shares Outstanding - Current
2.28M
Total Liabilities
6.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-69.047
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of biodefense vaccines and oral therapeutic products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com